South San Francisco, CA March 22, 2018 Genentech Press Release First and only prefilled syringe treatment option FDA-approved to treat all forms of diabetic retinopathy in people with or without diabetic macular edema (DME) Diabetic retinopathy is the leading…
Tag: FDA
FDA Approves Genentech’s Hemlibra (Emicizumab-kxwh) for Hemophilia A with Inhibitors
South San Francisco, CA November 16, 2017 Genentech Press Release First new medicine in nearly 20 years to treat people with hemophilia A with inhibitors HEMLIBRA substantially reduced bleeds in adults and children Only medicine that can be…
FDA Approves Rituxan Hycela (Rituximab and Hyaluronidase Human) for Subcutaneous Injection in Certain Blood Cancers
South San Francisco, CA June 23, 2017 Genentech Press Release Treatment can be administered in five to seven minutes, compared to 1.5 hours or more for intravenous Rituxan — SOUTH SAN FRANCISCO, CA — 2017-06-22 00:00:00 Genentech, a member…
FDA Approves Genentech’s OCREVUS™ (Ocrelizumab) For Relapsing and Primary Progressive Forms of Multiple Sclerosis
South San Francisco, CA March 29, 2017 Genentech Press Release First and only approved disease-modifying therapy for primary progressive form of multiple sclerosis (PPMS) – one of the most disabling forms of multiple sclerosis (MS) An…